Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
IRDCompany Name
OPUS GENETICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQOPUS GENETICS INC - Price to Earnings Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
IRD - P/E Historical data
| Date | Market Capitalization | Net Income Common Stock | Price to Earnings |
|---|---|---|---|
| 6/30/2025 | $ 65.9M | $ -58.27M | 0 |
| 3/31/2025 | $ 56.68M | $ -58.62M | 0 |
| 12/31/2024 | $ 44.67M | $ -57.53M | 0 |
| 9/30/2024 | $ 35.99M | $ -27.19M | 0 |
| 6/30/2024 | $ 34.32M | $ -14.11M | 0 |
| 3/31/2024 | $ 44.59M | $ -11.3M | 0 |
| 12/31/2023 | $ 49.38M | $ -9.99M | 0 |
| 9/30/2023 | $ 65.2M | $ 28.75M | 2.27 |
| 6/30/2023 | $ 88.65M | $ 18.66M | 4.75 |
| 3/31/2023 | $ 105.18M | $ 18.69M | 5.63 |
Key Performance Insights, Last 5 Years
- OPUS GENETICS INC's latest trailing twelve months (TTM) P/E stands at 0.
- Over the past 5 years, OPUS GENETICS INC's average P/E has been 4.28.
- The median P/E for OPUS GENETICS INC during this period was 4.62
- OPUS GENETICS INC reached its highest P/E over the past 5 years at 5.63.
- The lowest P/E recorded by OPUS GENETICS INC in the same timeframe 2.27
Similar metrics to P/E:
- Earnings Yield - [Calculation] The Earnings Yield, also known as the inverse of the PE ratio [PE], expresses a company’s earnings [NetIncCmn] as a percentage of [MarketCap].
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
Definition of Price to Earnings
[Calculation] Measures a company’s [MarketCap] in relation to its Net Income [NetIncCmn]. A high P/E ratio indicates that investors anticipate greater future earnings growth compared to companies with a lower P/E.Market Cap / Net Inc. Cmn.
(=) P/E P/E for OPUS GENETICS INC is calculated as follows: Market Cap [ $ 9.77M ] / Net Inc. Cmn. [ $ -6.37M ]
(=) P/E [ 0 ] IRD - Price to Earnings, Last 5 years
2.27
Minimum
Sep 30, 2023
5.63
Maximum
Mar 31, 2023
4.28
Average
4.62
Median
P/E Benchmark AnalysisMarket
The chart above depicts the distribution of P/E for companies in the Total Stock Market. The average P/E of the companies is 22.52 with a standard deviation of 13.96.
The following table provides additional summary stats:
P/E in the Market:
| filtered constituents | 2.08K |
|---|---|
| min | 0.13 |
| max | 70.11 |
| average | 22.52 |
| median | 18.89 |
| std | 13.96 |